Loading...
Loading...
Credit Suisse initiated coverage on
Lantheus Holdings Inc LNTH with a Outperform rating. The target price for Lantheus Holdings is set to $10. Lantheus Holdings shares closed at $7.47 on Friday.
Analysts at Brean Capital initiated coverage on
Ashford Hospitality Prime Inc AHP with a Buy rating. The target price for Ashford Hospitality Prime is set to $19. Ashford Hospitality Prime shares closed at $15.53 on Friday.
Analysts at Piper Jaffray initiated coverage on
Zeltiq Aesthetics Inc ZLTQ with a Overweight rating. The target price for Zeltiq Aesthetics is set to $35. Zeltiq Aesthetics shares closed at $30.52 on Friday.
Analysts at UBS initiated coverage on
Gener8 Maritime Inc GNRT with a Buy rating. The target price for Gener8 Maritime is set to $21. Gener8 Maritime shares closed at $14.21 on Friday.
Cowen & Company initiated coverage on
Catabasis Pharmaceuticals Inc CATB with a Outperform rating. The target price for Catabasis Pharmaceuticals is set to $30. Catabasis Pharmaceuticals shares closed at $14.05 on Friday.
Analysts at Baird initiated coverage on
Paypal Holdings Inc PYPLV with a Outperform rating. The target price for Paypal Holdings is set to $45. Paypal Holdings shares closed at $38.39 on Friday.
Analysts at JP Morgan initiated coverage on
Loading...
Loading...
with a Overweight rating. The target price for Glaukos is set to $38. Glaukos shares closed at $31.95 on Friday.
Analysts at Credit Suisse initiated coverage on
Hertz Global Holdings Inc HTZ with a Outperform rating. The target price for Hertz Global is set to $23. Hertz Global shares closed at $19.01 on Friday.
JP Morgan initiated coverage on
Paypal Holdings Inc PYPLV with a Overweight rating. The target price for Paypal Holdings is set to $48. Paypal shares closed at $38.39 on Friday.
MLV & Co initiated coverage on
Abeona Therapeutics IncABEO with a Buy rating. The target price for Abeona Therapeutics is set to $15. Abeona Therapeutics shares closed at $6.00 on Friday.
Loading...
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in